BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 30067440)

  • 1. Pancreatic and bile duct cancer circulating tumor cells (CTC) form immune-resistant multi-cell type clusters in the portal venous circulation.
    Arnoletti JP; Fanaian N; Reza J; Sause R; Almodovar AJ; Srivastava M; Patel S; Veldhuis PP; Griffith E; Shao YP; Zhu X; Litherland SA
    Cancer Biol Ther; 2018; 19(10):887-897. PubMed ID: 30067440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pancreatic Ductal Adenocarcinoma (PDAC) circulating tumor cells influence myeloid cell differentiation to support their survival and immunoresistance in portal vein circulation.
    Arnoletti JP; Reza J; Rosales A; Monreal A; Fanaian N; Whisner S; Srivastava M; Rivera-Otero J; Yu G; Phanstiel Iv O; Altomare DA; Tran Q; Litherland SA
    PLoS One; 2022; 17(3):e0265725. PubMed ID: 35316296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Portal Venous Blood Circulation Supports Immunosuppressive Environment and Pancreatic Cancer Circulating Tumor Cell Activation.
    Arnoletti JP; Zhu X; Almodovar AJ; Veldhuis PP; Sause R; Griffith E; Corpus G; Chang JC; Fanaian N; Litherland SA
    Pancreas; 2017 Jan; 46(1):116-123. PubMed ID: 27400259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. KRAS mutations in pancreatic circulating tumor cells: a pilot study.
    Kulemann B; Liss AS; Warshaw AL; Seifert S; Bronsert P; Glatz T; Pitman MB; Hoeppner J
    Tumour Biol; 2016 Jun; 37(6):7547-54. PubMed ID: 26684803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A High Circulating Tumor Cell Count in Portal Vein Predicts Liver Metastasis From Periampullary or Pancreatic Cancer: A High Portal Venous CTC Count Predicts Liver Metastases.
    Tien YW; Kuo HC; Ho BI; Chang MC; Chang YT; Cheng MF; Chen HL; Liang TY; Wang CF; Huang CY; Shew JY; Chang YC; Lee EY; Lee WH
    Medicine (Baltimore); 2016 Apr; 95(16):e3407. PubMed ID: 27100430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acquisition of Portal Venous Circulating Tumor Cells From Patients With Pancreaticobiliary Cancers by Endoscopic Ultrasound.
    Catenacci DV; Chapman CG; Xu P; Koons A; Konda VJ; Siddiqui UD; Waxman I
    Gastroenterology; 2015 Dec; 149(7):1794-1803.e4. PubMed ID: 26341722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating tumor cells (Ctc) and kras mutant circulating free Dna (cfdna) detection in peripheral blood as biomarkers in patients diagnosed with exocrine pancreatic cancer.
    Earl J; Garcia-Nieto S; Martinez-Avila JC; Montans J; Sanjuanbenito A; Rodríguez-Garrote M; Lisa E; Mendía E; Lobo E; Malats N; Carrato A; Guillen-Ponce C
    BMC Cancer; 2015 Oct; 15():797. PubMed ID: 26498594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CTC phenotyping for a preoperative assessment of tumor metastasis and overall survival of pancreatic ductal adenocarcinoma patients.
    Sun Y; Wu G; Cheng KS; Chen A; Neoh KH; Chen S; Tang Z; Lee PF; Dai M; Han RPS
    EBioMedicine; 2019 Aug; 46():133-149. PubMed ID: 31375425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Portal vein-circulating tumor cells predict liver metastases in patients with resectable pancreatic cancer.
    Bissolati M; Sandri MT; Burtulo G; Zorzino L; Balzano G; Braga M
    Tumour Biol; 2015 Feb; 36(2):991-6. PubMed ID: 25318603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Circulating tumor cells in pancreatic cancer : Results of morphological and molecular analyses and comparisons with the primary tumor].
    Timme-Bronsert S; Bronsert P; Werner M; Kulemann B; Höppner J
    Pathologe; 2018 Dec; 39(Suppl 2):311-314. PubMed ID: 30483865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Homogeneous pancreatic cancer spheroids mimic growth pattern of circulating tumor cell clusters and macrometastases: displaying heterogeneity and crater-like structure on inner layer.
    Feng H; Ou BC; Zhao JK; Yin S; Lu AG; Oechsle E; Thasler WE
    J Cancer Res Clin Oncol; 2017 Sep; 143(9):1771-1786. PubMed ID: 28497169
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Reza J; Almodovar AJ; Srivastava M; Veldhuis PP; Patel S; Fanaian N; Zhu X; Litherland SA; Arnoletti JP
    Epigenet Insights; 2019; 12():2516865719828348. PubMed ID: 30815628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence and comparative outcomes of periampullary cancer: A population-based analysis demonstrating improved outcomes and increased use of adjuvant therapy from 2004 to 2012.
    Hester CA; Dogeas E; Augustine MM; Mansour JC; Polanco PM; Porembka MR; Wang SC; Zeh HJ; Yopp AC
    J Surg Oncol; 2019 Mar; 119(3):303-317. PubMed ID: 30561818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Malignant portal venous obstructions treated by stent placement: significant factors affecting patency.
    Yamakado K; Nakatsuka A; Tanaka N; Fujii A; Terada N; Takeda K
    J Vasc Interv Radiol; 2001 Dec; 12(12):1407-15. PubMed ID: 11742015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PMN-MDSCs Enhance CTC Metastatic Properties through Reciprocal Interactions via ROS/Notch/Nodal Signaling.
    Sprouse ML; Welte T; Boral D; Liu HN; Yin W; Vishnoi M; Goswami-Sewell D; Li L; Pei G; Jia P; Glitza-Oliva IC; Marchetti D
    Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31003475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular detection of epithelial-mesenchymal transition markers in circulating tumor cells from pancreatic cancer patients: Potential role in clinical practice.
    Zhao XH; Wang ZR; Chen CL; Di L; Bi ZF; Li ZH; Liu YM
    World J Gastroenterol; 2019 Jan; 25(1):138-150. PubMed ID: 30643364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytologic characteristics of circulating epithelioid cells in pancreatic disease.
    Rosenbaum MW; Cauley CE; Kulemann B; Liss AS; Castillo CF; Warshaw AL; Lillemoe KD; Thayer SP; Pitman MB
    Cancer Cytopathol; 2017 May; 125(5):332-340. PubMed ID: 28257167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pancreatic tumors and immature immunosuppressive myeloid cells in blood and spleen: role of inhibitory co-stimulatory molecules PDL1 and CTLA4. An in vivo and in vitro study.
    Basso D; Fogar P; Falconi M; Fadi E; Sperti C; Frasson C; Greco E; Tamburrino D; Teolato S; Moz S; Bozzato D; Pelloso M; Padoan A; De Franchis G; Gnatta E; Facco M; Zambon CF; Navaglia F; Pasquali C; Basso G; Semenzato G; Pedrazzoli S; Pederzoli P; Plebani M
    PLoS One; 2013; 8(1):e54824. PubMed ID: 23359812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNAs and Neutrophil Activation Markers Predict Venous Thrombosis in Pancreatic Ductal Adenocarcinoma and Distal Extrahepatic Cholangiocarcinoma.
    Oto J; Navarro S; Larsen AC; Solmoirago MJ; Plana E; Hervás D; Fernández-Pardo Á; España F; Kristensen SR; Thorlacius-Ussing O; Medina P
    Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32012923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating tumor cells found in patients with localized and advanced pancreatic cancer.
    Kulemann B; Pitman MB; Liss AS; Valsangkar N; Fernández-Del Castillo C; Lillemoe KD; Hoeppner J; Mino-Kenudson M; Warshaw AL; Thayer SP
    Pancreas; 2015 May; 44(4):547-50. PubMed ID: 25822154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.